# A De Novo CaSR Missense Variant in Combination with Two Inherited Missense Variants in CFTR and SPINK1 Detected in a Patient with Chronic Pancreatitis

**Authors:** Piera Bontempo, Cecilia Surace, Lucia Menale, Claudia Alicata, Gemma D’Elia, Anna Cristina Tomaiuolo, Daniele Minervino, Elisa Lorefice, Antonio Novelli

PMC · DOI: 10.3390/biomedicines12061278 · 2024-06-09

## TL;DR

A patient with chronic pancreatitis was found to have three genetic variants, including a new one, that may contribute to the disease.

## Contribution

Identification of a de novo pathogenic variant in CaSR alongside inherited variants in CFTR and SPINK1 in a chronic pancreatitis case.

## Key findings

- A de novo CaSR variant (p.Phe790Ser) was classified as likely pathogenic.
- Two inherited variants in CFTR and SPINK1 were identified but had uncertain or benign significance.
- Rare variants in multiple genes may interact to cause chronic pancreatitis.

## Abstract

Chronic pancreatitis is often secondary to alcohol abuse, but pancreatitis with no other aetiology is frequently associated with variants in genes encoding proteins related to zymogen granule activation. Our goal was to identify genomic variants in a patient by analyzing an extended panel of genes associated with the intra-pancreatic activation of the trypsin pathway. A 23-year-old woman was addressed at our institution because of chronic pancreatitis of unknown aetiology presenting recurrent episodes since she was the age of four. Next Generation Sequencing was performed to analyze a panel of nine genes associated with pancreatitis (CaSR, CFTR, CPA1, CTRC, CTSB, KRT8, PRSS1, PRSS2, and SPINK1). Three missense variants were found: p.Leu997Phe, maternally inherited, in the CFTR gene; p.Ile73Phe, paternally inherited, in the SPINK1 gene; and p.Phe790Ser, a de novo variant, in the CaSR gene. They were classified, respectively as probably benign, a Variant of Uncertain Significance, and the last one, which has never been described in the literature, as likely being pathogenic following American College of Medical Genetics and Genomics standard guidelines. Extensive intra-pancreatic activation of trypsin pathway gene sequencing detected rare variants that were not found with other gene screening and showed that variants in different genes may interact in contributing to the onset of the pancreatitis phenotype.

## Linked entities

- **Genes:** CASR (calcium sensing receptor) [NCBI Gene 846], CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080], CPA1 (carboxypeptidase A1) [NCBI Gene 1357], CTRC (chymotrypsin C) [NCBI Gene 11330], CTSB (cathepsin B) [NCBI Gene 1508], KRT8 (keratin 8) [NCBI Gene 3856], PRSS1 (serine protease 1) [NCBI Gene 5644], PRSS2 (serine protease 2) [NCBI Gene 5645], SPINK1 (serine peptidase inhibitor Kazal type 1) [NCBI Gene 6690]
- **Diseases:** chronic pancreatitis (MONDO:0005003)

## Full-text entities

- **Genes:** CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080] {aka ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR}, PRSS2 (serine protease 2) [NCBI Gene 5645] {aka TRY2, TRY8, TRYP2}, KRT8 (keratin 8) [NCBI Gene 3856] {aka CARD2, CK-8, CK8, CYK8, K2C8, K8}, SPINK1 (serine peptidase inhibitor Kazal type 1) [NCBI Gene 6690] {aka PCTT, PSTI, Spink3, TATI, TCP}, CASR (calcium sensing receptor) [NCBI Gene 846] {aka CAR, EIG8, FHH, FIH, GPRC2A, HHC}, CTRC (chymotrypsin C) [NCBI Gene 11330] {aka CLCR, ELA4}, CPA1 (carboxypeptidase A1) [NCBI Gene 1357] {aka CPA}, CTSB (cathepsin B) [NCBI Gene 1508] {aka APPS, CPSB, KWE, RECEUP}, PRSS1 (serine protease 1) [NCBI Gene 5644] {aka TRP1, TRY1, TRY4, TRYP1}
- **Diseases:** alcohol abuse (MESH:D000437), pancreatitis (MESH:D010195), Chronic Pancreatitis (MESH:D050500)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** p.Phe790Ser, p.Leu997Phe, p.Ile73Phe

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11201075/full.md

---
Source: https://tomesphere.com/paper/PMC11201075